Search Results 1571-1580 of 19973 for Receptor

  1. Medical Research & Education - Mayo Clinic News Network

    Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to ...

  2. Medical Research & Education - Mayo Clinic News Network

    Do environmental exposures contribute to human diseases? · Research · Medical Innovation · Science Saturday: Addressing the challenges of chimeric antigen receptor ...

  3. Medical Research & Education - Mayo Clinic News Network

    T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study. Cancer ; Research finds ethnoracial differences in Alzheimer's disease ...

  4. A Study To Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed And/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - Mayo Clinic

    * Prior autologous stem cell transplantation or chimeric antigen receptor T-cell therapy within 3 months before first dose of study drug * Prior allogeneic ...

  5. Named lectureships - Department of Biochemistry and Molecular Biology - Mayo Clinic Research

    His work included the discovery and mechanisms of serum response factor, the actions of epidermal growth factor receptor (c-erbB1), and the role of tissue ...

  6. Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women with Obesity - Mayo Clinic

    Contraindications to GLP-1 receptor agonist therapy as per Tirzepatide (Zepbound ®) label. Currently enrolled in another clinical study involving an ...

  7. Chlorpheniramine and codeine polistirex (oral route) - Side effects & dosage - Mayo Clinic

    Codeine polistirex and chlorpheniramine polistirex combination is used to treat cough and respiratory symptoms associated with a cold or allergy. Codeine ...

  8. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis - Mayo Clinic

    History of biologic (eg, anti-tumor necrosis factor agents, integrin receptor antagonists) use at any time. Antibiotic use within 7 days prior to the ...

  9. A Study Of Alternative Site Goserelin Acetate Injection For OFS In Local And Locally Advanced Premenopausal Breast Cancer - Mayo Clinic

    ... receptor positive breast cancer with plan to continue medical OFS for at least the next 12 months. ECOG Performance Status (PS) 0, 1 or 2 (Appendix I). Or ...

  10. Study of Pomalidomide and Low Dose Dexamethasone With or Without Pembrolizumab (MK-3475) in Refractory or Relapsed and Refractory Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183) - Mayo Clinic

    Has received prior therapy with an anti-programmed cell death 1 receptor (anti-PD-1), antiprogrammed death-ligand 1 (anti-PD-L1), anti-PD-L2, anti-CD137, or ...